Atricure Inc (NASDAQ: ATRC) on Tuesday, plunged -2.10% from the previous trading day, before settling in for the closing price of $26.15. Within the past 52 weeks, ATRC’s price has moved between $18.94 and $47.12.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 15.61% over the past five years. The company achieved an average annual earnings per share of -19.65%. With a float of $47.09 million, this company’s outstanding shares have now reached $47.53 million.
Let’s look at the performance matrix of the company that is accounted for 1200 employees. In terms of profitability, gross margin is 74.32%, operating margin of -8.1%, and the pretax margin is -9.13%.
Atricure Inc (ATRC) Insider and Institutional Ownership
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Atricure Inc is 3.30%, while institutional ownership is 104.25%. The most recent insider transaction that took place on Aug 15 ’24, was worth 84,245. In this transaction Director of this company sold 3,500 shares at a rate of $24.07, taking the stock ownership to the 8,970 shares. Before that another transaction happened on Aug 15 ’24, when Company’s Director proposed sale 3,500 for $24.07, making the entire transaction worth $84,245.
Atricure Inc (ATRC) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -19.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.00% during the next five years compared to -1.17% drop over the previous five years of trading.
Atricure Inc (NASDAQ: ATRC) Trading Performance Indicators
Atricure Inc (ATRC) is currently performing well based on its current performance indicators. A quick ratio of 2.93 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.86, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Atricure Inc (ATRC)
Atricure Inc (NASDAQ: ATRC) saw its 5-day average volume 0.49 million, a negative change from its year-to-date volume of 0.77 million. As of the previous 9 days, the stock’s Stochastic %D was 89.21%. Additionally, its Average True Range was 1.27.
During the past 100 days, Atricure Inc’s (ATRC) raw stochastic average was set at 76.64%, which indicates a significant decrease from 85.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.14% in the past 14 days, which was lower than the 57.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.93, while its 200-day Moving Average is $28.72. Nevertheless, the first resistance level for the watch stands at $26.22 in the near term. At $26.85, the stock is likely to face the second major resistance level. The third major resistance level sits at $27.19. If the price goes on to break the first support level at $25.25, it is likely to go to the next support level at $24.91. The third support level lies at $24.28 if the price breaches the second support level.
Atricure Inc (NASDAQ: ATRC) Key Stats
Market capitalization of the company is 1.25 billion based on 47,588K outstanding shares. Right now, sales total 399,250 K and income totals -30,440 K. The company made 116,270 K in profit during its latest quarter, and -8,010 K in sales during its previous quarter.
